Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
SWKS heads into its November 5 earnings date with a contradictory setup: short interest near a multi-month high, borrow availability collapsing over the past week, and two analysts moving in opposite directions on the same day.
Short interest climbed to 21.8% of free float as of October 6, up roughly 6.7% on the week and back to levels last seen in mid-September. The move accelerated sharply: shares short jumped nearly 1.8 million in a single session on October 6, the biggest one-day addition in the 30-day window. That puts SWKS near the top of the most-shorted names in the semiconductor space. The borrow market has tightened noticeably to match. Availability dropped from roughly 90% a week ago to 51.9% now, a fall of 43% in seven days, which means the lending pool has gone from well-supplied to moderately constrained in rapid order. The 52-week low for availability was 31.2%, hit in late August, so there is room for further tightening if short demand continues to build. Cost to borrow remains low at 0.63%, up about 13% on the week but still not pricing in stress. The ORTEX short score has edged up to 69.4 from 67.4 a week ago, reflecting the combination of rising short interest and tightening availability.
Options traders are sitting in a similarly cautious posture. The put/call ratio is running at 1.23, modestly above its 20-day average of 1.19, placing it near the middle of its recent range but well above the 52-week low of 0.28. The reading has been sticky in the 1.25 to 1.26 band for most of the past week before easing slightly on October 6. The overall skew confirms that buyers of downside protection are active but not panicked, protective rather than aggressive.
The Street sent a mixed signal on October 6 itself. B. Riley upgraded SWKS to Buy and lifted its target from $68 to $107, an unusually large move, while Citigroup kept a Neutral rating and raised its target from $64 to $90. Both revisions followed the stock's 11.8% gain over the prior month, suggesting some analysts are marking up after the price rather than leading it. The consensus remains firmly at Hold, with 19 Hold ratings against just 2 Buys, and the mean price target of $75.12 sits roughly 9% below the current $82.79 close. That is an unusual configuration: the stock is trading above where the average analyst thinks it should be, even after the target upgrades. Factor scores add some nuance: the 30-day EPS momentum rank is at the 90th percentile and the 12-month forward EPS year-on-year increase ranks at the 88th percentile, both suggesting the earnings trajectory has improved meaningfully. The EV/EBITDA multiple has compressed around 7.4 turns over the past week, which partly explains why value-oriented investors see appeal even with bears present.
The bull case centres on Skyworks' Broad Markets segment, which has posted nine consecutive quarters of revenue growth, with Wi-Fi 7, automotive, and AI data-centre products growing roughly 30% year over year in the March quarter. A potential merger with QRVO adds a strategic dimension, with the deal offering scale, defence and aerospace diversification, and an estimated $500 million in cost synergies. Bears counter that iPhone content erosion is a real risk, particularly with a higher Pro mix in the iPhone 17 cycle, and that the SAMR phase 2 review could push the QRVO deal close to end of 2026 or into early 2027, leaving a prolonged period of regulatory uncertainty. QRVO itself fell 2.2% on the week while SWKS dropped 6%. CRUS and QCOM both lost around 1.6% to 1.7%, suggesting broad sector pressure rather than stock-specific weakness at SWKS.
On the ownership register, FMR LLC (Fidelity) filed a fresh Schedule 13G on October 7 disclosing a 12.6% stake of roughly 19 million shares, and Capital World Investors filed on October 6 with a 10.1% position. These are passive filings, not activist 13Ds, and there are no 13D activists on the register. Stakes are as-last-disclosed around the 5% threshold; holders dropping below 5% may exit without a further filing. The Vanguard Group's 13G shows a position that has moved to zero from 13.95% previously, though separate Vanguard entities (Portfolio Management and Capital Management) still hold a combined roughly 14%. T. Rowe Price reported a 7.8% stake in August after nearly doubling its position, a meaningful accumulation. The most recent insider activity was the CFO exercising options and withholding shares for tax purposes in September, a compensation event rather than a conviction trade, and carries no signal.
The next scheduled earnings print on November 5 is the focal point. The last two results produced opposite same-day reactions: a 9.3% gain after the August 2026 report and a 3.5% decline after July's report, with both recovering over five days. The question heading into November is whether the Street's target-price upgrades reflect a genuine re-rating of the earnings outlook or are simply chasing the past month's price action, while short sellers are clearly not yet convinced.
See the live data behind this article on ORTEX.
Open SWKS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
